IRWD

Ironwood Pharmaceuticals, Inc.

9.26 USD
-5.86 (-38.76%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Ironwood Pharmaceuticals, Inc. stock is down -32.9% since 30 days ago. The next earnings date is May 2, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 42.86% of the previous 14 February’s closed higher than January. In the last 10 Unusual Options Trades, there were 4 CALLs, 6 PUTs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
22 Feb 19:10 19 Apr, 2024 15.00 CALL 150 20715
22 Feb 20:44 19 Apr, 2024 10.00 PUT 500 16228
26 Feb 14:54 19 Apr, 2024 10.00 PUT 369 17959
27 Feb 17:04 19 Apr, 2024 10.00 PUT 598 19104
28 Feb 15:28 19 Apr, 2024 17.50 CALL 2500 21337
28 Feb 15:28 19 Apr, 2024 15.00 CALL 280 20757
28 Feb 15:38 19 Apr, 2024 17.50 CALL 2500 21337
29 Feb 14:33 19 Apr, 2024 12.50 PUT 150 7086
29 Feb 14:43 19 Apr, 2024 12.50 PUT 200 7086
29 Feb 14:55 19 Apr, 2024 10.00 PUT 812 20523

About Ironwood Pharmaceuticals, Inc.

Ironwood Pharmaceuticals, Inc. focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation.